Respiratory
Pneumothorax
8
Pipeline Programs↗
1
Active Trials↗
3
Companies Involved↗
Pneumothorax is an early-stage landscape with 8 programs across 3 companies. The most active players are GSK, Triax, Scilex Pharmaceuticals, Inc.. 1 therapy is approved with 1 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Preclinical1
Phase 24
Approved1
Analysis
Trial Status
8
clinical trials
Unknown status5 · 63%
Withdrawn1 · 13%
Completed1 · 13%
Recruiting1 · 13%
Clinical Trials
Trial Activity
8 trials
Does Non-Steroidal Anti-inflammatory Drugs Decrease the Quality of Pleurodesis After Mechanical Pleural Abrasion/Pleurectomy for Treatment of Pneumothorax?
Recruiting·—·Phase 1/2·NCT06467318·116 enrolled
Efficacy, Safety and Re-occurrence of Pneumothorax and Hydro-pneumothorax With Talc and Pyodine Pleurodesis
Unknown status·—·Phase 1/2·NCT04130451·104 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)